Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-Ab™
Target-Humanized Mouse Models (HUGO-GT™)
Target-Humanized Mouse Models (CDS)
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Custom Model Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Preclinical Solutions
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic
Obesity
MASH & MASLD
Cardiovascular
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Retinal-related diseases
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Drug Classification
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
iCyagen
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Company Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeResource RepositoryHUmanized Genomic Ortholog (HUGO™) mouse models enable preclinical evaluation of human-targeted siRNA and antisense oligonucleotide therapies
Poster

HUmanized Genomic Ortholog (HUGO™) mouse models enable preclinical evaluation of human-targeted siRNA and antisense oligonucleotide therapies

Introducing the HUGO™ (HUmanized Genomic Ortholog) platform, which uses TurboKnockout™ technology to swap up to 500 kb of mouse genomic sequence for the human ortholog — promoters, exons, introns, and UTRs intact — and validates two such models with an approved siRNA and a splice-modulating ASO.
HUmanized Genomic Ortholog (HUGO™) mouse models enable preclinical  evaluation of human-targeted siRNA and antisense oligonucleotide therapies

Overview

siRNA and ASO therapeutics depend on human transcript sequence and regulatory context, which cDNA-based rodent models cannot reproduce because they omit introns and native regulatory regions. The HUGO™ platform replaces up to 500 kb of murine locus with the corresponding human genomic ortholog, retaining promoters, exons, introns, and UTRs. In B6-hPCSK9 mice on a high-fat, high-cholesterol diet, a single subcutaneous dose of Inclisiran lowered serum LDL-C and significantly reduced serum and hepatic human PCSK9 by Day 19. In B6-huSMN2(SMA) mice, ICV ASO-10-27 raised brain SMN protein, preserved spinal anterior horn motor neurons, and extended median survival from 29 days to beyond 140 days.

Key Insights

HUGO™ mouse models replace the mouse locus with the full human genomic ortholog: introns, UTRs, and regulatory elements included, enabling preclinical evaluation of sequence-dependent siRNA and ASO therapeutics, as validated with Inclisiran and an SMN2 splice-modulating ASO.
  • Genomic-scale humanization that preserves regulatory architecture. TurboKnockout™ enables replacement of up to 500 kb of the endogenous mouse locus with human genomic sequence, retaining promoters, exons, introns, and UTRs — the elements that cDNA-based models omit but on which siRNA and ASO recognition depends.
  • Pharmacological validation with an approved siRNA. B6-hPCSK9 mice on a Western diet responded to a single 3 mg/kg subcutaneous dose of Inclisiran with reduced serum LDL-C and significantly decreased serum and hepatic human PCSK9 at Day 19, recapitulating the expected RNAi mechanism.
  • Disease-modifying ASO response in an SMA model. In B6-huSMN2(SMA) mice, ICV-delivered ASO-10-27 increased brain SMN protein and anterior horn motor neuron counts, and shifted survival from a 29-day median (death by ~40 days) to first deaths only at 140 days, with markedly delayed tail and paw lesions.
Unlock Advanced Research Insights with Cyagen’s Resources
Explore an array of valuable resources tailored to enhance your preclinical research. Download mateirals meticulously crafted to provide advanced insights and methodologies. Elevate your research strategies with Cyagen's expertise.
Download Details
Full Name
Email
Organization
Job Role
Country
Main Area of Research
Resource Preferences
Which type of solutions are you considering?
Do you plan to start a project with us within the next 6 months?
How did you hear about us?
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCompany OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2026 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research